Albumin Administration for Large Volume Paracentesis

Rationale for Albumin Administration

The European Association for the Study of the Liver recommends large volume paracentesis (LVP) as the first-line treatment for large (grade 3) ascites in patients with cirrhosis, but it can cause significant hemodynamic changes that may lead to circulatory dysfunction 1, 3
Post-paracentesis circulatory dysfunction (PPCD) is characterized by a reduction in effective blood volume that can lead to rapid re-accumulation of ascites, hepatorenal syndrome, hyponatremia, and increased mortality 3
The removal of large volumes of ascitic fluid causes a marked reduction in intra-abdominal and inferior vena cava pressure, leading to decreased right atrial pressure and pulmonary capillary wedge pressure 4
Without volume expansion, these hemodynamic changes can lead to activation of the renin-angiotensin-aldosterone system, resulting in renal impairment and electrolyte disturbances 5

The American Association for the Study of Liver Diseases recommends albumin administration at a dose of 8 g per liter of ascitic fluid removed during LVP of more than 5 liters to prevent PPCD 1, 2
Albumin should be given as a 20% or 25% solution after the paracentesis is completed 4, 6
The albumin should be administered slowly to avoid cardiac overload, especially in patients with latent cirrhotic cardiomyopathy 3

Albumin is more effective than other plasma expanders (dextran-70, polygeline) in preventing PPCD, particularly when more than 5 liters of ascites are removed 3
The use of artificial plasma expanders is associated with significantly greater activation of the renin-angiotensin-aldosterone system 5
Albumin administration is associated with a lower incidence of hyponatremia (8% vs 17%) compared to other plasma expanders 5
Despite higher initial costs, albumin is more cost-effective than alternative plasma expanders due to fewer liver-related complications within 30 days post-paracentesis 3

Albumin administration post-paracentesis is associated with lower number of liver-related complications within 30 days 1
Albumin administration post-paracentesis is associated with decreased risk of renal impairment 4
Albumin administration post-paracentesis is associated with improved survival (the severity of PPCD correlates inversely with patient survival) 4

LVP should be performed under strict sterile conditions using disposable sterile materials 1
After LVP, patients should receive the minimum dose of diuretics necessary to prevent re-accumulation of ascites 1
The risk of PPCD increases with >8 L of fluid evacuated in one single session 7

Failure to administer albumin after LVP >5 L can lead to PPCD with impaired renal function and electrolyte disturbances 5
Administering albumin too rapidly can cause cardiac overload in patients with cirrhotic cardiomyopathy 3
Limiting paracentesis volume to <8 L per session may help preserve renal function and improve survival 7